Journals / Cyprus Journal of Medical Sciences / 2022 / Cilt: 7 - Sayı: 3

The Comparison of the Differentiation Potential of Periodontal Ligament and Dental Pulp Mesenchymal Stem Cells in the Inflammatory Synovium Microenvironment

Pages
387–394
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

RESULTS: The cytokines interleukin (IL)-1β (61.1±9.8) and IL-6 (2386.7±397.4) were significantly higher in the end-stage RA-SF samples, compared to the early-stage RA-SF samples (IL-1β:35.2±4.8, IL-6:561.3±197.6) (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:BACKGROUND/AIMS: Dental mesenchymal stem cells are easily accessible sources for mesenchymal stem cells (MSCs) and can rapidly proliferate in culture conditions.
📊
Key Findings & Data:MATERIALS AND METHODS: Synovial fluid samples (8-10 mL/patient) were collected from patients with RA (age; 48−67 years).
💡
Conclusion & Impact:RESULTS: The cytokines interleukin (IL)-1β (61.1±9.8) and IL-6 (2386.7±397.4) were significantly higher in the end-stage RA-SF samples, compared to the early-stage RA-SF samples (IL-1β:35.2±4.8, IL-6:561.3±197.6) (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

BACKGROUND/AIMS: Dental mesenchymal stem cells are easily accessible sources for mesenchymal stem cells (MSCs) and can rapidly proliferate in culture conditions. Rheumatoid arthritis (RA) is a chronic and multi-systemic autoimmune inflammatory disease that results in cartilage damage. The present study aimed to investigate the regenerative potential of dental MSCs in the synovial fluid microenvironment of patients with RA. MATERIALS AND METHODS: Synovial fluid samples (8-10 mL/patient) were collected from patients with RA (age; 48−67 years). Dental pulp (DP) and periodontal ligament (PL) tissues were collected from healthy individuals, and the tissues were enzymatically digested in 3 mg/mL collagenase type I. MSCs were cultured in Dulbecco’s Modified Eagle Medium (DMEM). The cells were cultured in the presence and absence of the synovial fluid samples of the patients with RA and subjected to flow cytometry analysis for cell surface expressions of positive markers for chondrogenesis (CD49e) and an osteogenic marker (alkaline phosphatase; ALP). The differentiation capacity of MSCs was evaluated with osteogenic or chondrogenic stimulation media and analyzed by staining the cells with Alizarin Red or Alcian Blue, respectively. RESULTS: The cytokines interleukin (IL)-1β (61.1±9.8) and IL-6 (2386.7±397.4) were significantly higher in the end-stage RA-SF samples, compared to the early-stage RA-SF samples (IL-1β:35.2±4.8, IL-6:561.3±197.6) (p

🔖

Cite This Article

GENÇ, D., GÜNAYDIN, B., SEZGİN, S., ALADAĞ, A., TARHAN, E. F. (2022). The Comparison of the Differentiation Potential of Periodontal Ligament and Dental Pulp Mesenchymal Stem Cells in the Inflammatory Synovium Microenvironment. Cyprus Journal of Medical Sciences, Cilt: 7 - Sayı: 3, 387–394. https://ajindex.com/articles/482136

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Sharpe PT. Dental mesenchymal stem cells. Development. 2016; 143(13): 2273-80
  2. Shi Y, Wang Y, Li Q, Liu K, Hou J, Shao C, et al. Immunoregulatory mechanisms of mesenchymal stem and stromal cells in inflammatory diseases. Nat Rev Nephrol. 2018; 14(8): 493-507
  3. Ballini A, Scacco S, Coletti D, Pluchino S, Tatullo M. Mesenchymal Stem Cells as Promoters, Enhancers, and Playmakers of the Translational Regenerative Medicine. Stem Cells Int. 2017; 2017: 3292810
  4. Rivera-Cruz CM, Shearer JJ, Figueiredo Neto M, Figueiredo ML. The Immunomodulatory Effects of Mesenchymal Stem Cell Polarization within the Tumor Microenvironment Niche. Stem Cells Int. 2017; 2017: 4015039
  5. Guo Q, Wang Y, Xu D, Nossent J, Pavlos NJ, Xu J. Rheumatoid arthritis: pathological mechanisms and modern pharmacologic therapies. Bone Res. 2018; 6: 15
  6. Lettesjö H, Nordström E, Ström H, Nilsson B, Glinghammar B, Dahlstedt L, et al. Synovial fluid cytokines in patients with rheumatoid arthritis or other arthritic lesions. Scand J Immunol. 1998; 48(3): 286-92
  7. Ridgley LA, Anderson AE, Pratt AG. What are the dominant cytokines in early rheumatoid arthritis? Curr Opin Rheumatol. 2018; 30(2): 207-14
  8. Köhler BM, Günther J, Kaudewitz D, Lorenz HM. Current Therapeutic Options in the Treatment of Rheumatoid Arthritis. J Clin Med. 2019; 8(7): 938
  9. Barnes PJ. Corticosteroids: the drugs to beat. Eur J Pharmacol. 2006; 533(1- 3): 2-14
  10. Yildirim S, Zibandeh N, Genc D, Ozcan EM, Goker K, Akkoc T. The Comparison of the Immunologic Properties of Stem Cells Isolated from Human Exfoliated Deciduous Teeth, Dental Pulp, and Dental Follicles. Stem Cells Int. 2016; 2016: 4682875
  11. Dăcălescu A, Zlei M, Aanei C, Ungureanu D, Tepeluş M, Burcoveanu C, et al. Flow cytometry-based quantification of cytokine levels in AML patients plasma and cell culture supernatants. Rev Med Chir Soc Med Nat Iasi. 2008; 112(1): 196-202
  12. Grässel S, Stöckl S, Jenei-Lanzl Z. Isolation, culture, and osteogenic/ chondrogenic differentiation of bone marrow-derived mesenchymal stem cells. Methods Mol Biol. 2012; 879: 203-67
  13. Arpornmaeklong P, Brown SE, Wang Z, Krebsbach PH. Phenotypic characterization, osteoblastic differentiation, and bone regeneration capacity of human embryonic stem cell-derived mesenchymal stem cells. Stem Cells Dev. 2009; 18(7): 955-68
  14. Newman RE, Yoo D, LeRoux MA, Danilkovitch-Miagkova A. Treatment of inflammatory diseases with mesenchymal stem cells. Inflamm Allergy Drug Targets. 2009